Editorial: Cancer stem cells as attractive targets for breast cancer therapy.
作者信息
Ibrahim Sherif Abdelaziz, Yip George W, Götte Martin
机构信息
Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt.
Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
出版信息
Front Oncol. 2023 Mar 3;13:1151742. doi: 10.3389/fonc.2023.1151742. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Cancer stem cells as attractive targets for breast cancer therapy.社论：癌症干细胞作为乳腺癌治疗的诱人靶点
Front Oncol. 2023 Mar 3;13:1151742. doi: 10.3389/fonc.2023.1151742. eCollection 2023.
2
Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer.基于组织的乳腺癌干细胞鉴定及上皮-间充质转化。
Hum Pathol. 2013 Aug;44(8):1457-64. doi: 10.1016/j.humpath.2013.01.005. Epub 2013 Apr 8.
3
Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.肿瘤起始能力与乳腺癌细胞系中上皮-间充质转化状态无关。
Br J Cancer. 2014 May 13;110(10):2514-23. doi: 10.1038/bjc.2014.153. Epub 2014 Apr 22.
4
Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.重新审视癌症转移中的上皮-间质转化：上皮可塑性与干性之间的联系。
Mol Oncol. 2017 Jul;11(7):792-804. doi: 10.1002/1878-0261.12096. Epub 2017 Jun 26.
5
The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment.乳腺癌上皮间质转化与缺氧微环境的关系机制。
Biomed Pharmacother. 2016 May;80:393-405. doi: 10.1016/j.biopha.2016.02.044. Epub 2016 Apr 17.
6
The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.基质细胞蛋白CCN6（WISP3）可降低Notch1水平并抑制乳腺癌起始细胞。
Oncotarget. 2016 May 3;7(18):25180-93. doi: 10.18632/oncotarget.7734.
7
Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition.化生性乳腺癌富含肿瘤起始细胞和上皮间质转化的标志物。
Mod Pathol. 2012 Feb;25(2):178-84. doi: 10.1038/modpathol.2011.167. Epub 2011 Nov 11.
8
Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.上皮-间质转化、肿瘤微环境与上皮性恶性肿瘤的转移行为
Int J Biochem Mol Biol. 2012;3(2):117-36. Epub 2012 May 18.
9
Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.大黄素通过抑制巨噬细胞诱导的乳腺癌细胞上皮-间充质转化和癌症干细胞形成来减少乳腺癌肺转移。
Theranostics. 2020 Jul 9;10(18):8365-8381. doi: 10.7150/thno.45395. eCollection 2020.
10
MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.微小RNA调控上皮-间质转化并影响乳腺癌的侵袭和转移。
Tumour Biol. 2017 Feb;39(2):1010428317691682. doi: 10.1177/1010428317691682.
引用本文的文献
1
Targeting CSC-immune cell crosstalk to overcome chemoresistance and enhance immunotherapy efficacy.靶向癌症干细胞-免疫细胞间的相互作用以克服化疗耐药性并提高免疫治疗疗效。
Front Immunol. 2025 Jul 23;16:1620807. doi: 10.3389/fimmu.2025.1620807. eCollection 2025.
本文引用的文献
1
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer.异质性乳腺癌的靶向治疗与免疫治疗
Cancers (Basel). 2022 Nov 6;14(21):5456. doi: 10.3390/cancers14215456.
3
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.耐药性乳腺癌干细胞样细胞：克服耐药性的机制及新型治疗策略综述
Front Oncol. 2022 Mar 21;12:856974. doi: 10.3389/fonc.2022.856974. eCollection 2022.
4
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.通过对预后相关基因、驱动基因、信号通路和免疫活性进行多组学分析揭示乳腺癌亚型特异性分子特征
Front Cell Dev Biol. 2021 Jul 1;9:689028. doi: 10.3389/fcell.2021.689028. eCollection 2021.
5
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.C-X-C基序趋化因子配体1维持乳腺癌干细胞自我更新并促进肿瘤进展和免疫逃逸程序。
Front Cell Dev Biol. 2021 Jun 14;9:689286. doi: 10.3389/fcell.2021.689286. eCollection 2021.
6
The Breast Cancer Stem Cells Traits and Drug Resistance.乳腺癌干细胞特性与耐药性
Front Pharmacol. 2021 Jan 28;11:599965. doi: 10.3389/fphar.2020.599965. eCollection 2020.
7
The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties.硫酸乙酰肝素磺基转移酶HS2ST1和HS3ST2是乳腺癌干细胞特性的新型调节因子。
Front Cell Dev Biol. 2020 Sep 25;8:559554. doi: 10.3389/fcell.2020.559554. eCollection 2020.
8
The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.硫酸乙酰肝素蛋白聚糖 syndecan-1 通过粘着斑激酶-Wnt 信号轴调控结肠癌细胞干细胞功能。
FEBS J. 2021 Jan;288(2):486-506. doi: 10.1111/febs.15356. Epub 2020 May 25.
9
Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.肌球蛋白结合 RNA 结合蛋白敲低可降低三阴性乳腺癌的放射抵抗性，但增强细胞迁移和侵袭能力。
Int J Mol Sci. 2020 Mar 21;21(6):2169. doi: 10.3390/ijms21062169.
10
Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance.蛋白聚糖和糖胺聚糖作为癌症干细胞功能和治疗抵抗的调节剂。
FEBS J. 2019 Aug;286(15):2870-2882. doi: 10.1111/febs.14967. Epub 2019 Jun 27.
Zotero 插件